Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.
Data from a late-stage study shows that co-administering GSK's RSV and Shingles vaccines together was as effective as giving ...
UK drugmaker GSK presented positive Phase III trial data at the European Geriatric Medicine Society Congress. The trial ...